We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01021358
Recruitment Status : Completed
First Posted : November 30, 2009
Last Update Posted : December 20, 2010
Sponsor:
Information provided by:
Abbott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2010
  Study Completion Date : No date given